Biomolecular Mass Spectrometry and Proteomics Group, Bijvoet Centre for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.
Analyst. 2010 Oct;135(10):2643-52. doi: 10.1039/c0an00267d. Epub 2010 Aug 10.
Isobaric stable isotope labeling of peptides using iTRAQ is an important method for MS based quantitative proteomics. Traditionally, quantitative analysis of iTRAQ labeled peptides has been confined to beam-type instruments because of the weak detection capabilities of ion traps for low mass ions. Recent technical advances in fragmentation techniques on linear ion traps and the hybrid linear ion trap-orbitrap allow circumventing this limitation. Namely, PQD and HCD facilitate iTRAQ analysis on these instrument types. Here we report a method for iTRAQ-based relative quantification on the ETD enabled LTQ Orbitrap XL, which is based on parallel peptide quantification and peptide identification. iTRAQ reporter ion generation is performed by HCD, while CID and ETD provide peptide identification data in parallel in the LTQ ion trap. This approach circumvents problems accompanying iTRAQ reporter ion generation with ETD and allows quantitative, decision tree-based CID/ETD experiments. Furthermore, the use of HCD solely for iTRAQ reporter ion read out significantly reduces the number of ions needed to obtain informative spectra, which significantly reduces the analysis time. Finally, we show that integration of this method, both with existing CID and ETD methods as well as with existing iTRAQ data analysis workflows, is simple to realize. By applying our approach to the analysis of the synapse proteome from human brain biopsies, we demonstrate that it outperforms a latest generation MALDI TOF/TOF instrument, with improvements in both peptide and protein identification and quantification. Conclusively, our work shows how HCD, CID and ETD can be beneficially combined to enable iTRAQ-based quantification on an ETD-enabled LTQ Orbitrap XL.
采用 iTRAQ 的等压稳定同位素标记肽是基于 MS 的定量蛋白质组学的重要方法。传统上,由于离子阱对低质量离子的检测能力较弱,iTRAQ 标记肽的定量分析仅限于束流型仪器。最近,线性离子阱和混合线性离子阱-轨道阱在碎裂技术方面的技术进步使得能够克服这一限制。即 PQD 和 HCD 促进了这些仪器类型上的 iTRAQ 分析。在这里,我们报告了一种基于 ETD 的 LTQ Orbitrap XL 上基于 iTRAQ 的相对定量方法,该方法基于平行肽定量和肽鉴定。iTRAQ 报告离子的生成是通过 HCD 进行的,而 CID 和 ETD 在 LTQ 离子阱中平行提供肽鉴定数据。这种方法避免了 ETD 生成 iTRAQ 报告离子时伴随的问题,并允许进行基于定量、决策树的 CID/ETD 实验。此外,仅使用 HCD 进行 iTRAQ 报告离子读出显著减少了获得有意义谱所需的离子数量,从而显著缩短了分析时间。最后,我们证明了这种方法与现有的 CID 和 ETD 方法以及现有的 iTRAQ 数据分析工作流程的集成非常简单。通过将我们的方法应用于人脑活检的突触蛋白质组分析,我们证明它优于最新一代 MALDI TOF/TOF 仪器,在肽和蛋白质鉴定和定量方面都有改进。总之,我们的工作表明 HCD、CID 和 ETD 如何可以有益地结合,以在 ETD 启用的 LTQ Orbitrap XL 上实现基于 iTRAQ 的定量。